Iambic Therapeutics, Inc. (NASDAQ:IAM)
| Market Cap | 133.69M-16.0% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 9.38M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 609,517 |
| Open | 14.50 |
| Previous Close | 14.67 |
| Day's Range | 13.02 - 14.63 |
| 52-Week Range | 13.02 - 25.00 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
Iambic Therapeutics, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About IAM
Iambic Therapeutics, Inc. develops AI driven platform for drug discovery. It combines proprietary AI-driven platforms with the expertise of experienced drug discovery scientists to identify, design, and optimize novel therapeutic candidates across a range of disease areas. The company was founded by Thomas Miller and Fred Manby on October 14, 2019 and is headquartered in San Diego, CA.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$IAM stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in IAM holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by IAM's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
IAM Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New IAM patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to IAM from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in IAM
| ETF | Est. Holding Size |
|---|---|
| ARKGARK Genomic Revolution ETF | $19.42M |
| CANCTema Oncology ETF | $916.88K |
| HLTHTema Healthcare AI ETF | $160.09K |
Estimated from each fund’s disclosed top holdings × AUM
IAM Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from IAM’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score